Agreement combines Baird Medical's clinical, regulatory, and global commercialization expertise with Alpmed's leadership in IRE technology Collaboration will advance technology development, global regulatory approvals, commercialization, and clinical adoption across key international markets,
First procedures in two new markets highlight growing global adoption of Baird Medical's minimally invasive microwave ablation technology NEW YORK, June 29, 2026 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a market leader in minimally
Enhanced U.S. Presence Centralizes Operations as Company Executes Global Growth Strategy NEW YORK, June 9, 2026 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a market leader in minimally invasive Microwave Ablation (MWA) technology, today
Full year 2025 revenue of $22.5 million, impacted by policy-driven slowdown in Mainland China Advancing global expansion with appointment of seasoned commercial leader, Mark Saxton, as CEO of Baird Medical U.S. to lead commercial ramp in the United States NEW YORK, April 29, 2026 /PRNewswire/ --
NEW YORK, March 16, 2026 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a market leader in minimally invasive Microwave Ablation (MWA) technology, today announced the successful execution of two clinical training workshops in Indonesia.